What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary areas of investigation include Immunology, Internal medicine, Inflammatory bowel disease, Crohn's disease and Gastroenterology.
While the research belongs to areas of Immunology, Matthieu Allez spends his time largely on the problem of Cell biology, intersecting his research to questions surrounding Interleukin-7 receptor and Interleukin 13.
In his research, Colectomy is intimately related to Surgery, which falls under the overarching field of Internal medicine.
His Inflammatory bowel disease study combines topics from a wide range of disciplines, such as Antigen and Ulcerative colitis.
The various areas that he examines in his Crohn's disease study include Infliximab and Retrospective cohort study.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Discontinuation, Adverse effect, Primary sclerosing cholangitis, Prospective cohort study and C-reactive protein.
His most cited work include:
- CEACAM6 acts as a receptor for adherent-invasive E. coli , supporting ileal mucosa colonization in Crohn disease (412 citations)
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial (360 citations)
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Crohn's disease, Gastroenterology, Inflammatory bowel disease and Immunology are his primary areas of study.
In the field of Internal medicine, his study on Ulcerative colitis, Infliximab, Disease and Retrospective cohort study overlaps with subjects such as In patient.
His studies deal with areas such as Prospective cohort study, Surgery, Refractory, Adverse effect and Cohort as well as Crohn's disease.
His biological study spans a wide range of topics, including Colectomy, Primary sclerosing cholangitis, Incidence and Endoscopy.
The study incorporates disciplines such as Rheumatoid arthritis and Intensive care medicine in addition to Inflammatory bowel disease.
His research ties NKG2D and Immunology together.
He most often published in these fields:
- Internal medicine (47.40%)
- Crohn's disease (40.83%)
- Gastroenterology (31.14%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (47.40%)
- Crohn's disease (40.83%)
- Inflammatory bowel disease (30.45%)
In recent papers he was focusing on the following fields of study:
Matthieu Allez mainly focuses on Internal medicine, Crohn's disease, Inflammatory bowel disease, Ulcerative colitis and Gastroenterology.
His Crohn's disease study incorporates themes from Cumulative incidence and Surgery, Endoscopy, Transplantation.
He interconnects Irritable bowel syndrome, Disease severity, Immunology and Intensive care medicine in the investigation of issues within Inflammatory bowel disease.
His Immunology research integrates issues from Hematopoietic stem cell transplantation and Stem cell.
His studies in Ulcerative colitis integrate themes in fields like Cross-sectional study, Colitis and Hazard ratio.
Matthieu Allez has researched Gastroenterology in several fields, including Pouch, Area under the curve, Interquartile range, Incidence and Refractory.
Between 2018 and 2021, his most popular works were:
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
- Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
- Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Matthieu Allez mostly deals with Crohn's disease, Internal medicine, Disease, Inflammatory bowel disease and Immune system.
His study in Crohn's disease is interdisciplinary in nature, drawing from both Gastroenterology, Odds ratio, Pathogenesis and Enthesitis.
His study in the field of Autoimmune enteropathy also crosses realms of Ruxolitinib.
His Inflammatory bowel disease research incorporates elements of Inflammation, Concomitant, Transmission and Intensive care medicine.
His Immune system study integrates concerns from other disciplines, such as Cell, Antibody and NKG2D.
His study explores the link between Cohort and topics such as Metabolite that cross with problems in Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
